Recent information

Welcome to our investor section!


You will find the most recent information and reports about Exentis here.


Recent investor news

  • 24.03.2023
    Exentis’ licensee Laxxon Medical enters into a cooperation with Hovione for the industrial manufacturing of 3D printed tablets
    • Conclusion of a long-term strategic cooperation agreement between Laxxon Medical and Hovione, a leading manufacturer in the pharmaceutical industry
    • Accelerated establishment of the Exentis clean room 3D technology platform within the pharmaceutical industry
    • Large-scale production of innovative 3D printed tablets with a freely adjustable release profile for the active pharmaceutical ingredients
  • 22.02.2023
    Third 3D production system delivered to Ohnhäuser
    • Contract manufacturing capacity for Exentis customers significantly increased to 10 million parts
    • Production and development cooperation with Ohnhäuser further extended
    • Exentis 3D production system delivered within six weeks
  • 17.01.2023
    Ohnhäuser acquires third Exentis 3D production system
    • Ohnhäuser being the exclusive contract manufacturer for Exentis since 2019
    • Significant expansion of contract manufacturing capacity for Exentis customers
    • Series production capacity increased to more than 10 million parts per year
All investor news

Recent reports

  • Half-year report 2022
  • Annual report 2021
  • Half-year report 2021
All reports

Contact us